Navigation
Trademark Information
Application ID
Status
Date of Application
18 February 2021
Classes
42
Proprietor
Flat No. 102. E Block. Ramki One Marval, Gajularamaram, Hyderabad, Rangareddy, Telangana 500055
Attorney
Sneha Manjooran[32262]
F 97, 4th Floor, Anna Nagar (East), Chennai 600102, Tamil Nadu.
Type
Device
State
Telangana
Country
Filing Mode
e-Filing
IP Office
CHENNAI
Used Since
Valid / Upto
18 February 2031
Description
[Class : 42] Scientific And Technological Services And Research And Design Relating Thereto; Industrial Analysis, Industrial Research And Industrial Design Services; Quality Control And Authentication Services; Design And Development Of Computer Hardware And Software
Image (DEVICE)
Documents
| Examination Report |
Uploaded Documents
| 1 | TM-A(TRADE MARKS APPLICATION) | 18 Feb 2021 |
| 2 | Journal Copy | 24 Mar 2021 |
| 3 | Journal Copy | 24 Mar 2021 |
| 4 | Journal Copy | 24 Mar 2021 |
| 5 | Journal Copy | 24 Mar 2021 |
| 6 | Journal Copy | 24 Mar 2021 |
| 7 | Certificate | 30 Jul 2021 |
Frequently Asked Questions
When was the trademark applied?
The application for Intelli fettle - reimagining the future of healthcare was made on 18 February 2021.
Who is the applicant for Intelli fettle - reimagining the future of healthcare?
The trademark applicant for Intelli fettle - reimagining the future of healthcare is INTELLI FETTLE TECHNOLOGIES.
In what class is the trademark applied to?
Intelli fettle - reimagining the future of healthcare is applied in class(es) 42.
What is the status of the trademark application?
Application for Intelli fettle - reimagining the future of healthcare is on Registered stage.
What is the application ID of the trademark?
Application Id allotted to Intelli fettle - reimagining the future of healthcare is 4868927.
Who is the trademark agent or attorney?
Trademark agent or attorney for the application is Sneha Manjooran.
What is the type of trademark application?
Intelli fettle - reimagining the future of healthcare filed with the Intellectual property office as a DEVICE.